Results 71 to 80 of about 45,683 (251)
Naloxone distribution programs in the emergency department: A scoping review of the literature
Journal of the American College of Emergency Physicians OpenThis scoping review summarized the literature regarding naloxone distribution from emergency departments (EDs) without a prescription. Our intention was to examine various naloxone distribution programs, their methodologies, and the level of ...
Mohan K. Sindhwani +4 more
doaj +1 more source
Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery
VIEW, EarlyView.This study provides a comprehensive and up‐to‐date analysis of recent progress in HMN technology, covering fundamental transdermal delivery mechanisms and design principles, biomaterials used in HMN fabrication, drug loading and release strategies, and emerging therapeutic applications.
Mohammad Muhtasim Ittisaf +5 more
wiley +1 more source
Rapid widespread distribution of intranasal naloxone for overdose prevention
, 2017 Background: In order to have a substantial impact on overdose prevention, the expansion and scalingup of overdose prevention with naloxone distribution (OPEND) programs are needed.
Lobmaier, Philipp Paul +2 more
core +1 more source
Intention to get naloxone among patients prescribed opioids for chronic pain
Harm Reduction Journal, 2022 Background Prescription opioids have been increasingly prescribed for chronic pain while the opioid-related death rates grow. Naloxone, an opioid antagonist, is increasingly recommended in these patients, yet there is limited research that investigates ...
Yinan Huang +5 more
doaj +1 more source
The Milbank Quarterly, EarlyView.Policy Points The liberalization of medical and recreational cannabis policies may increase cannabis initiation across age groups, with increased prevalence of cannabis use among young adults and adults and weaker effects among youth. Evidence also suggests increases in cannabis‐related health care utilization among adults.
SARAH B. WINDLE +8 more
wiley +1 more source
Naloxone for opioid overdose - Pharmacological aspects and dosing in clinical practice [PDF]
, 2020 Dødsfall fra opioidoverdoser er et stort folkehelseproblem og utdeling av nesespray med motgiften nalokson var foreslått som et tiltak for å redde liv. I 2012 fantes det ingen godkjente nesesprayer på markedet. Istedenfor var improviserte, ikke-godkjente
Tylleskär, Ida Karin
core +1 more source
Harm Reduction JournalIntroduction Despite reductions in overdose deaths reported nationally in 2025, overdose remains a leading cause of death in Michigan and the broader United States.
Pamela S. Lynch +6 more
doaj +1 more source
Addiction, Volume 120, Issue 4, Page 745-755, April 2025.Abstract Aims The aim of this study was to identify longitudinal trajectories of medication for opioid use disorder (MOUD) use throughout 1 year following MOUD initiation and to examine the association of trajectory membership with HIV testing among people who inject drugs in India.
Allison M. McFall +8 more
wiley +1 more source
Naloxone induced pulmonary edema
, 2021 Naloxone-induced noncardiogenic pulmonary edema is a rare but reported entity that can occur following naloxone use in the reversal of opioid overdose.
Ramez Alyacoub +4 more
core +1 more source
What anabolic–androgenic steroids reveal about the limits of current harm reduction models
Addiction, EarlyView.Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski +2 more
wiley +1 more source